|
Earlier this week, Seattle’s Tableau Software announced a big jump in annual sales and major hiring plans—something that’s becoming almost routine for those watching the Stanford-bred data-analysis software company’s growth.
Now entering its tenth year, Tableau recently opened a London office and... Read more »
[Updated: 3:47 pm] Amylin Pharmaceuticals and Alkermes have gone to the FDA twice before to seek approval of their new diabetes drug, and been turned back, but now the persistence has paid off. The FDA has cleared their once-weekly... Read more »
I don’t think there’s ever been a textbook that made it this easy to be a good student. —Roger Rosner, vice president of productivity applications, Apple
Whenever a company as powerful as Apple, Facebook, or Google announces a big new product push, it evokes wonder... Read more »
Bad news out today from Infinity Pharmaceuticals. The Cambridge, MA-based biotech company said it is halting a mid-stage clinical trial of its drug for pancreatic cancer early after learning that patients were living longer in the placebo comparison group. Infinity (NASDAQ: INFI... Read more »
Rising stars in the local startup community BarkBox, HackNY, and Gotham Greens will be on hand at Xconomy Forum: New York’s Venture Emergence event on Feb. 1. They will enlighten the crowd with “burst” presentations, during which they’ll describe their companies... Read more »
It’s that outlook time of year, and Mark Heesen, president of the National Venture Capital Association (NVCA), was in San Diego earlier this week, talking about the 2012 outlook for venture capital. Today he’ll make a similar presentation to the New Jersey... Read more »
It’s a question as old as human nature. You’ve heard the stories, you know all the famous examples. Steve Jobs, Larry Ellison, Michael Eisner, the list goes on. All difficult characters with strong personalities—and hugely successful companies.
So, in today’s ultra-competitive tech... Read more »
President and CEO, BayBio
Assoc. Dean of Translational Health Sciences, Univ. of Washington
Co-Founder and CEO, Genoptix
Partner, Business Law Department, Goodwin Proctor
Managing Partner, Triathalon Medical Ventures Fund II
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.
